GL1X · GenesisL1 explorer

MolNFT v1 · #60501 · protein

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-met in complex with a aminopyridine based inhibitor

3CTJ: “Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor C-met in complex…”. X-ray diffraction, 1 ligand (320), 2 pockets (best druggability 0.68). MolNFT v1 #60501 on GenesisL1: 3D structure, binding…

PDB
3CTJ
Type
protein
Length
289 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hepatocyte growth factor receptor
EC
2.7.10.1
UniProt
P08581
Ligands
320
Pockets
2 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 34% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHepatocyte growth factor receptor (EC 2.7.10.1)protein28934% helix, 15% strandP08581

Ligands and binding sites

  • 320 · 2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13500.680.8132320
21780.520.7828empty

Compared structures

  • 3CTJ · Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.